Last reviewed · How we verify

Probiotics (Lacidofil®) — Competitive Intelligence Brief

Probiotics (Lacidofil®) (Probiotics (Lacidofil®)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Probiotic. Area: Gastroenterology.

marketed Probiotic Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Probiotics (Lacidofil®) (Probiotics (Lacidofil®)) — Chuncheon Sacred Heart Hospital. Lacidofil® is a probiotic formulation that restores beneficial gut microbiota to improve intestinal health and immune function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Probiotics (Lacidofil®) TARGET Probiotics (Lacidofil®) Chuncheon Sacred Heart Hospital marketed Probiotic
Probiotic Vivomixx Probiotic Vivomixx University of Milan marketed Probiotic
Mesalazine plus Lactobacillus casei Mesalazine plus Lactobacillus casei Hospital Cristo Re marketed Anti-inflammatory agent plus probiotic combination
"AS-Probionorm" "AS-Probionorm" Industrial Microbiology LLP marketed Probiotic
Akkermansia muciniphila + Infliximab Akkermansia muciniphila + Infliximab Chinese Medical Association marketed Combination therapy: probiotic + TNF-α inhibitor TNF-α (infliximab component); gut microbiota modulation (Akkermansia muciniphila component)
Combizym + Bifidobacteri Combizym + Bifidobacteri RenJi Hospital marketed Enzyme and probiotic combination
Probiotic capsules Probiotic capsules Sahlgrenska University Hospital marketed Probiotic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Probiotic class)

  1. BioBalance Corporation · 1 drug in this class
  2. Biocodex · 1 drug in this class
  3. CD Pharma India Pvt. Ltd. · 1 drug in this class
  4. CHU de Quebec-Universite Laval · 1 drug in this class
  5. Chuncheon Sacred Heart Hospital · 1 drug in this class
  6. Dow University of Health Sciences · 1 drug in this class
  7. Federico II University · 1 drug in this class
  8. Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan · 1 drug in this class
  9. GWT-TUD GmbH · 1 drug in this class
  10. Aga Khan University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Probiotics (Lacidofil®) — Competitive Intelligence Brief. https://druglandscape.com/ci/probiotics-lacidofil. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: